Theranostics · 2020 · 28 citations · 40 references
MedicineCardiologyPharmacologyCardio-oncologyChemotherapyPediatric CardiologyAnthracycline CardiotoxicityBiomarkers In Cardio-oncologyCancer Therapy-related CardiotoxicityCardiac BiomarkersCardiac Risk AssessmentHeart FailureAcute Cardiac ToxicityAnthracycline-induced CardiotoxicityBiomarkers Of Anthracycline CardiotoxicityCardiotoxicityDoxorubicin CardiotoxicityEarly Detection Of CardiotoxicityPediatric Anthracycline CardiotoxicityPediatric Cancer Cardiotoxicity
Our data suggest that screening of the contractile defaults of the base of the heart by regional 2D strain echocardiography is useful to detect subclinical myocardial dysfunction prior to the development of delayed anthracycline-induced cardiomyopathy in pediatric onco-cardiology.
40
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang, Xiaobing Liu, Tasneem Bawa‐Khalfe et al. · Nature Medicine · 2012 · 1.9K citations
Medicine, Biochemistry, Pharmacology +14
Juan Carlos Plana, Maurizio Galderisi, Ana Barac et al. · Journal of the American Society of Echocardiography · 2014 · 1.8K citations · Full text
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Daniela Cardinale, Alessandro Colombo, Giulia Bacchiani et al. · Circulation · 2015 · 1.7K citations
Medicine, Cardiology, Oncology +16
Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy
Laurel J. Steinherz · JAMA · 1991 · 966 citations
Medicine, Cardiology, Oncology +16